01.07.2006 | Phase II Studies
A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma
Erschienen in: Investigational New Drugs | Ausgabe 4/2006
Einloggen, um Zugang zu erhalten